🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
No prospective randomized trials have evaluated the most efficacious dose o...
Status
Completed
Location
Dartmouth Hitchcock Medical Center
Start Date
2013-12
Trial ID
NCT02139280
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Status
Unknown
Location
HSCT department
Start Date
2021-04-14
Trial ID
NCT04844177
Treatments Being Tested
This is a phase I, prospective clinical trial studying the safety and feasi...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2025-09-25
Trial ID
NCT07052370
The goal of this clinical research is to learn if treatment with high-dose ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-03
Trial ID
NCT01003054
Treatments Being Tested
This phase I trial investigates the side effects and best dose of CD19 posi...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-06-26
Trial ID
NCT03579888
Treatments Being Tested
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
Background: Peripheral blood stem cell transplantation procedures are used...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2017-04-06
Trial ID
NCT03077542
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842